Aarti Drugs Ltd
NSE: AARTIDRUGS BSE: 524348
₹367
(-0.65%)
Wed, 11 Mar 2026, 03:18 am
Market Cap33.5B
PE Ratio16.53
Dividend0.54
Health Technology
Pharmaceuticals: Major
24.5KAarti Drugs Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.54B | 2.89B | 3.12B | 3.78B | 4.79B | 5.01B | 6.59B | 8.25B | 9.70B | 10.94B | 11.35B | 11.95B | 12.44B | 15.61B | 18.06B | 21.55B | 24.89B | 27.16B | 25.21B | 23.79B |
| Gross profit | 254.64M | 303.54M | 311.65M | 503.07M | 929.74M | 791.36M | 766.30M | 1.26B | 1.58B | 1.73B | 1.74B | 1.93B | 2.11B | 2.21B | 2.99B | 4.89B | 3.89B | 3.69B | 3.64B | 3.46B |
| Operating expenses (excl. COGS) | -2.88M | -2.69M | -1.73M | -3.39M | -268.37M | -283.01M | -263.05M | -313.21M | -394.53M | -333.77M | -343.95M | -370.25M | -467.36M | -498.62M | -794.41M | -950.75M | -1.02B | -1.04B | -950.64M | -1.15B |
| Selling/general/admin expenses, total | — | — | — | — | -268.37M | -282.99M | -263.05M | -313.21M | -394.53M | -333.77M | -343.95M | -370.25M | -467.36M | -496.11M | -755.95M | -942.28M | -998.71M | -1.03B | -931.68M | -1.11B |
| Research & development | — | -14.98M | — | — | -45.52M | -43.75M | -23.71M | -31.28M | -38.66M | -30.40M | -38.76M | -38.01M | -40.77M | -39.78M | -44.29M | -46.64M | -43.58M | -64.72M | -83.45M | -130.42M |
| Selling/general/admin expenses, other | — | — | — | — | -222.85M | -239.23M | -239.34M | -281.93M | -355.87M | -303.38M | -305.19M | -332.24M | -426.58M | -456.32M | -711.66M | -895.64M | -955.14M | -964.13M | -848.23M | -983.06M |
| Other operating expenses, total | -2.88M | -2.69M | -1.73M | -3.39M | -1.69K | -24.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.51M | -38.46M | -8.47M | -16.86M | -15.30M | -18.96M | -37.22M |
| Operating income | 251.76M | 285.87M | 309.92M | 499.68M | 661.37M | 508.35M | 503.25M | 948.13M | 1.18B | 1.40B | 1.40B | 1.56B | 1.64B | 1.71B | 2.19B | 3.94B | 2.87B | 2.65B | 2.69B | 2.31B |
| Non-operating income, total | -81.25M | -96.85M | -110.70M | -240.85M | -187.34M | -177.25M | -181.05M | -289.35M | -336.92M | -401.55M | -448.24M | -398.61M | -393.82M | -396.57M | -338.63M | -251.25M | -171.55M | -406.37M | -331.22M | -191.85M |
| Interest expense, net of interest capitalized | -87.45M | -104.46M | -128.77M | -243.54M | -165.97M | -149.18M | -226.72M | -280.36M | -334.90M | -422.83M | -480.15M | -400.17M | -383.57M | -435.06M | -374.24M | -262.31M | -239.08M | -371.38M | -378.88M | -390.38M |
| Interest capitalized | 0 | 0 | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 162.63M | 128.78M |
| Non-operating income, excl. interest expenses | 6.20M | 7.61M | 18.06M | 2.69M | -21.37M | -28.07M | 57.30M | -4.63M | -2.54M | 21.28M | -3.01M | 20.87M | -10.26M | 38.49M | 35.61M | 41.47M | 67.53M | -34.99M | 50.58M | 198.53M |
| Non-operating interest income | 2.64M | 3.82M | 6.46M | 706.43K | 890.20K | 928.90K | 8.45M | 1.60M | 13.22M | 4.22M | 6.64M | 5.37M | 7.14M | 11.60M | 11.26M | 25.96M | 7.17M | 6.99M | 24.95M | 123.96M |
| Miscellaneous non-operating expense | 3.56M | 3.79M | 11.60M | 1.99M | -22.26M | -29.00M | 48.85M | -6.23M | -15.77M | 17.06M | -9.65M | 15.50M | -17.40M | 26.88M | 24.35M | 15.51M | 60.36M | -41.98M | 25.62M | 74.56M |
| Unusual income/expense | — | — | — | — | — | — | -11.63M | -4.36M | 522.00K | — | 34.92M | -19.31M | — | 0 | 0 | -30.42M | 0 | 0 | -2.92M | 0 |
| Pretax income | 170.51M | 189.02M | 199.22M | 258.83M | 474.03M | 331.10M | 322.20M | 658.78M | 847.60M | 997.20M | 952.75M | 1.16B | 1.25B | 1.31B | 1.85B | 3.69B | 2.70B | 2.24B | 2.36B | 2.12B |
| Taxes | -25.50M | -41.40M | -51.10M | -83.14M | -190.29M | -95.56M | -106.16M | -206.40M | -239.65M | -224.65M | -265.50M | -342.10M | -421.96M | -412.72M | -438.90M | -886.16M | -649.59M | -578.25M | -639.37M | -436.74M |
| Non-controlling/minority interest | -7.42M | -8.34M | -7.28M | -8.56M | -3.76M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.00K | 147.00K | 428.00K | -484.00K | -1.73M | 615.00K |
| After tax other income/expense | -3.53M | -1.41M | -1.18M | -1.56M | 790.44K | -943.24K | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 134.06M | 137.68M | 137.37M | 159.66M | 279.70M | 237.62M | 216.04M | 452.38M | 607.95M | 772.54M | 687.25M | 818.02M | 823.07M | 897.51M | 1.41B | 2.80B | 2.05B | 1.66B | 1.71B | 1.68B |
| Net income | 134.06M | 137.68M | 137.37M | 159.66M | 279.70M | 237.62M | 216.04M | 452.38M | 607.95M | 772.54M | 687.25M | 818.02M | 823.07M | 897.51M | 1.41B | 2.80B | 2.05B | 1.66B | 1.71B | 1.68B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 134.06M | 137.68M | 137.37M | 159.66M | 279.70M | 237.62M | 216.04M | 452.38M | 607.95M | 772.54M | 687.25M | 818.02M | 823.07M | 897.51M | 1.41B | 2.80B | 2.05B | 1.66B | 1.71B | 1.68B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 373.81M | 415.93M | 451.29M | 644.81M | 831.70M | 699.43M | 745.41M | 1.21B | 1.47B | 1.71B | 1.77B | 1.94B | 2.04B | 2.13B | 2.68B | 4.44B | 3.37B | 3.15B | 3.20B | 2.87B |
| EBIT | 251.76M | 285.87M | 309.92M | 499.68M | 661.37M | 508.35M | 503.25M | 948.13M | 1.18B | 1.40B | 1.40B | 1.56B | 1.64B | 1.71B | 2.19B | 3.94B | 2.87B | 2.65B | 2.69B | 2.31B |
| Total operating expenses | -2.28B | -2.61B | -2.81B | -3.28B | -4.12B | -4.50B | -6.09B | -7.30B | -8.51B | -9.54B | -9.95B | -10.39B | -10.80B | -13.90B | -15.87B | -17.61B | -22.02B | -24.51B | -22.53B | -21.48B |
| Prepaid expenses | 126.37M | 155.94M | 22.98M | 25.43M | -770.91K | 30.95M | — | — | 146.66M | 201.53M | 232.60M | 329.95M | — | — | — | — | — | — | 27.84M | 34.51M |
| Deferred income, current | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 214.76M | 344.13M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 58.72M | 58.72M | 35.80M | 18.79M | 4.03M | 9.14M | 16.51M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 114.37M | 134.17M | 159.72M | 184.85M | 210.28M | 227.13M | 244.72M | 275.12M | 310.12M | 350.18M | 404.18M | 717.70M | 809.24M | 898.09M | 807.14M | 771.34M | 724.31M | 709.68M | 757.07M | 782.33M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 36.43M | 36.43M | 36.43M | 36.43M | 36.43M | — | — | — | — | — | — | — |
| Minority interest | 130.20M | 138.54M | 145.82M | 94.68M | 48.65M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -21.00K | -168.00K | -597.00K | 2.33M | 4.06M | 3.44M |
| Change in accrued expenses | — | 0 | 0 | 0 | 0 | 0 | — | 0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | — | -30.09M | 0 | -21.10M | -34.60M | -90.00M | -54.49M | -129.00M | -139.25M | -226.68M | -236.12M | 0 | -29.18M | -29.14M | -84.67M | -232.05M | -95.08M | -94.01M | -92.67M | -90.61M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800